Table I.
Characteristics of the examined groups
| Characteristics of the examined groups | Group I EF > 58% n = 20 | Group II EF < 58% n = 20 | Value of p |
|---|---|---|---|
| Age [years] | 58.1 ±17.7 | 55.3 ±25.6 | NS |
| Men [%] | 70 | 85 | NS |
| BMI [kg/m2] | 25.1 ±4.4 | 24.9 ±4 | NS |
| BSA | 1.9 ±0.2 | 1.9 ±0.2 | NS |
| IHD [%] | 25 | 60 | < 0.05 |
| Previous myocardial infarction [%] | 5 | 35 | < 0.05 |
| Heart failure [%] | 20 | 40 | NS |
| Previous CNS ischaemia [%] | 0 | 0 | NS |
| Previous CABG [%] | 0 | 5 | NS |
| Renal failure [%] | 10 | 5 | NS |
| Hypertension [%] | 75 | 70 | NS |
| Diabetes [%] | 0 | 20 | < 0.05 |
| Hypercholesterolaemia [%] | 45 | 50 | NS |
| Cigarette smoking [%] | 65 | 60 | NS |
| Abnormal ECG [%] | 25 | 60 | < 0.05 |
| Pathological Q waves [%] | 5 | 25 | < 0.05 |
| Wall motion abnor-malities at rest [%] | 5 | 45 | < 0.05 |
| LV hypertrophy [%] | 40 | 40 | NS |
| Abdominal aortic aneurysm [%] | 65 | 55 | NS |
| Leriche’s syndrome [%] | 35 | 45 | NS |
| ASA [%] | 20 | 75 | < 0.05 |
| ACEI [%] | 60 | 60 | NS |
| Sartans [%] | 10 | 5 | NS |
| α-Blockers [%] | 40 | 45 | NS |
| Calcium antagonists [%] | 15 | 10 | NS |
| Digoxin [%] | 0 | 0 | NS |
| Diuretics [%] | 20 | 30 | NS |
| Nitrates [%] | 0 | 25 | < 0.05 |
| Statins [%] | 30 | 55 | < 0.05 |
n – number of patients, p – difference significant, NS – difference statistically insignificant